CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...

Key opportunities in the market include leveraging CRISPR's precision for improved crop traits, meeting food security demands amid climate change, and sustainable agriculture trendsDublin, Dec. 09, ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...

A one-year-old baby boy has received an incredible honour, for helping researchers get one step closer to finding treatment ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

On November 18, 2025, ToolGen, Inc. (“ToolGen”) filed a complaint (“Complaint”) in the District of Massachusetts alleging infringement of its ...

DeepSeek's founder and CEO, Liang Wenfeng, has been listed among the top 10 "people who shaped science in 2025" by the ...

Lab-grown fungus ‘meat’ could be cheaper chicken substitute, scientists say - Natural texture and flavour of protein produced ...

Scientists have used a new type of gene therapy to cure leukaemia patients. The treatment, which uses edited immune cells ...